• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Absence of in vitro cross-reaction of pentasaccharide with the plasma heparin-dependent factor of twenty-five patients with heparin-associated thrombocytopenia.

作者信息

Elalamy I, Lecrubier C, Potevin F, Abdelouahed M, Bara L, Marie J P, Samama M

出版信息

Thromb Haemost. 1995 Nov;74(5):1384-5.

PMID:8607131
Abstract
摘要

相似文献

1
Absence of in vitro cross-reaction of pentasaccharide with the plasma heparin-dependent factor of twenty-five patients with heparin-associated thrombocytopenia.五糖与25例肝素相关性血小板减少症患者血浆肝素依赖因子无体外交叉反应。
Thromb Haemost. 1995 Nov;74(5):1384-5.
2
Clinical cross-reactivity between danaparoid and heparin antibodies successfully managed with bivalirudin.达那肝素与肝素抗体之间的临床交叉反应通过比伐卢定成功处理。
Isr Med Assoc J. 2009 Mar;11(3):188-90.
3
Additional anticoagulant strategies for managing heparin-induced thrombocytopenia.
Am J Health Syst Pharm. 1996 Apr 15;53(8):945. doi: 10.1093/ajhp/53.8.945.
4
Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes.肝素诱导的血小板减少症——与磺达肝癸钠和直接凝血酶抑制剂不同，达那肝素的治疗浓度可抑制血小板因子4-肝素复合物的形成。
J Thromb Haemost. 2008 Dec;6(12):2160-7. doi: 10.1111/j.1538-7836.2008.03171.x. Epub 2008 Oct 3.
5
Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparin.
Semin Thromb Hemost. 1991;17 Suppl 1:60-4.
6
Anticoagulation with recombinant hirudin and danaparoid sodium in pediatric patients.重组水蛭素和达那肝素钠在儿科患者中的抗凝作用。
Semin Thromb Hemost. 2002 Oct;28(5):447-54. doi: 10.1055/s-2002-35285.
7
Immunogenic but effective: the HIT-fondaparinux brain puzzler.具有免疫原性但有效：磺达肝癸钠诱导的血小板减少症难题。
J Thromb Haemost. 2011 Dec;9(12):2386-8. doi: 10.1111/j.1538-7836.2011.04511.x.
8
Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin-induced thrombocytopenia.肝素诱导的血小板减少症患者对四种低分子量肝素和类肝素ORG 10172的血小板聚集反应。
Br J Haematol. 1994 Feb;86(2):425-6. doi: 10.1111/j.1365-2141.1994.tb04760.x.
9
[Heparin-associated platelet aggregation syndrome with skin necrosis during hemodialysis].[血液透析期间伴有皮肤坏死的肝素相关性血小板聚集综合征]
Dtsch Med Wochenschr. 1997 Mar 14;122(11):328-32. doi: 10.1055/s-2008-1047617.
10
Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan.关于低分子量糖胺聚糖洛莫帕兰的药理学和临床研究。
Semin Thromb Hemost. 1991;17 Suppl 2:205-13.

引用本文的文献

1
When Will Fondaparinux Induce Thrombocytopenia?磺达肝癸钠何时会引起血小板减少症？
Bioconjug Chem. 2022 Aug 17;33(8):1574-1583. doi: 10.1021/acs.bioconjchem.2c00316. Epub 2022 Jul 25.
2
The Pharmacotherapy of Heparin-Induced Thrombocytopenia (HIT) : A Review of Contemporary Therapeutic Challenges in Clinical Practice.肝素诱导的血小板减少症（HIT）的药物治疗：临床实践中当代治疗挑战的综述
Malays J Med Sci. 2008 Apr;15(2):3-13.
3
[Orthopedic patients with or without thrombophilia. Diagnostic, therapy and peri-operative strategies].
[伴有或不伴有血栓形成倾向的骨科患者。诊断、治疗及围手术期策略]
Orthopade. 2009 Sep;38(9):835-42. doi: 10.1007/s00132-009-1455-1. Epub 2009 Sep 4.
4
New concepts in heparin-induced thrombocytopenia: diagnosis and management.肝素诱导的血小板减少症的新概念：诊断与管理
J Thromb Thrombolysis. 2006 Feb;21(1):17-21. doi: 10.1007/s11239-006-5571-z.
5
Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.接受磺达肝癸钠或依诺肝素抗血栓预防的骨科手术患者中的抗血小板因子4/肝素抗体
Blood. 2005 Dec 1;106(12):3791-6. doi: 10.1182/blood-2005-05-1938. Epub 2005 Aug 18.
6
New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin.新型抗凝剂：超越肝素、低分子量肝素和华法林。
Br J Pharmacol. 2005 Apr;144(8):1017-28. doi: 10.1038/sj.bjp.0706153.
7
Safety profile of tinzaparin administered once daily at a standard curative dose in two hundred very elderly patients.在两百名高龄患者中，以标准治疗剂量每日一次给予替扎肝素的安全性研究。
Drug Saf. 2002;25(10):725-33. doi: 10.2165/00002018-200225100-00005.
8
Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.达那肝素。其药理学及在肝素诱导的血小板减少症管理中的临床应用综述。
Drugs. 1997 Dec;54(6):903-24. doi: 10.2165/00003495-199754060-00008.
9
Heparin-induced thrombocytopenia. Pathogenesis, frequency, avoidance and management.
Drug Saf. 1997 Nov;17(5):325-41. doi: 10.2165/00002018-199717050-00005.